Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis

BackgroundIndividuals with multiple sclerosis (MS) are vulnerable to all types of infection, because MS itself involves immunodeficiency, in addition to involving treatment with immunosuppressants. Simple predictive variables for infection that are easily assessed in daily examinations are warranted...

Full description

Bibliographic Details
Main Authors: Junichiro Takahashi, Tomoko Okamoto, Youwei Lin, Reiko Saika, Atsuko Katsumoto, Wakiro Sato, Takashi Yamamura, Yuji Takahashi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1133444/full
_version_ 1811163588411260928
author Junichiro Takahashi
Tomoko Okamoto
Youwei Lin
Reiko Saika
Atsuko Katsumoto
Wakiro Sato
Takashi Yamamura
Yuji Takahashi
author_facet Junichiro Takahashi
Tomoko Okamoto
Youwei Lin
Reiko Saika
Atsuko Katsumoto
Wakiro Sato
Takashi Yamamura
Yuji Takahashi
author_sort Junichiro Takahashi
collection DOAJ
description BackgroundIndividuals with multiple sclerosis (MS) are vulnerable to all types of infection, because MS itself involves immunodeficiency, in addition to involving treatment with immunosuppressants. Simple predictive variables for infection that are easily assessed in daily examinations are warranted. Lymphocyte area under the curve (L_AUC), defined as the sum of serial absolute lymphocyte counts under the lymphocyte count-time curve, has been established as a predictive factor for several infections after allogenic hematopoietic stem cell transplantation. We assessed whether L_AUC could also be a useful factor for predicting severe infection in MS patients.MethodsFrom October 2010 to January 2022, MS patients, diagnosed based on the 2017 McDonald criteria, were retrospectively reviewed. We extracted patients with infection requiring hospitalization (IRH) from medical records and matched with controls in a 1:2 ratio. Variables including clinical severity and laboratory data were compared between the infection group and controls. L_AUC was calculated along with the AUC of total white blood cells (W_AUC), neutrophils (N_AUC), lymphocytes (L_AUC), and monocytes (M_AUC). To correct for different times of blood examination and extract mean values of AUC per time point, we divided the AUC by follow-up duration. For example, in evaluating lymphocyte counts, we defined the ratio of [L_AUC] to [follow-up duration] as [L_AUC/t]. Multivariate regression analysis was conducted to extract predictive factors associated with IRH. Also, discriminative analysis was conducted using candidate variables from multivariate analysis.ResultsThe total case-control sample included 177 patients of MS with IRH (n=59) and non-IRH (controls) (n=118). Adjusted odds ratios (OR) for the risk of serious infection in patients with MS with higher baseline expanded disability status scale (EDSS) (OR 1.340, 95% confidence interval [CI] 1.070–1.670, p = 0.010) and lower ratio of L_AUC/t to M_AUC/t (OR 0.766, 95%CI 0.591–0.993, p = 0.046) were significant. Notably, the kind of treatment, including glucocorticoids (GCs), disease-modifying drugs (DMDs) and other immunosuppressants agents, and dose of GCs were not significantly associated with serious infection after correlated with EDSS and ratio of L_AUC/t to M_AUC/t. In discriminative analysis, sensitivity was 88.1% (95%CI 76.5–94.7%) and specificity was 35.6% (95%CI 27.1–45.0%), using EDSS ≥ 6.0 or ratio of L_AUC/t to M_AUC/t ≤ 3.699, while sensitivity was 55.9% (95%CI 42.5–68.6%) and specificity was 83.9% (95%CI 75.7–89.8%), using both EDSS ≥ 6.0 and ratio of L_AUC/t to M_AUC/t ≤ 3.699.ConclusionOur study revealed the impact of the ratio L_AUC/t to M_AUC/t as a novel prognostic factor for IRH. Clinicians should pay more attention to laboratory data such as lymphocyte or monocyte counts itself, directly presenting individual immunodeficiency, rather than the kind of drug to prevent infection as a clinical manifestation.
first_indexed 2024-04-10T15:07:46Z
format Article
id doaj.art-b058f1beba7e4c198d06d36223b86ee4
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T15:07:46Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-b058f1beba7e4c198d06d36223b86ee42023-02-14T19:54:07ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-02-011410.3389/fimmu.2023.11334441133444Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosisJunichiro Takahashi0Tomoko Okamoto1Youwei Lin2Reiko Saika3Atsuko Katsumoto4Wakiro Sato5Takashi Yamamura6Yuji Takahashi7Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, JapanDepartment of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, JapanDepartment of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, JapanDepartment of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, JapanDepartment of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, JapanDepartment of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, JapanDepartment of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, JapanDepartment of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, JapanBackgroundIndividuals with multiple sclerosis (MS) are vulnerable to all types of infection, because MS itself involves immunodeficiency, in addition to involving treatment with immunosuppressants. Simple predictive variables for infection that are easily assessed in daily examinations are warranted. Lymphocyte area under the curve (L_AUC), defined as the sum of serial absolute lymphocyte counts under the lymphocyte count-time curve, has been established as a predictive factor for several infections after allogenic hematopoietic stem cell transplantation. We assessed whether L_AUC could also be a useful factor for predicting severe infection in MS patients.MethodsFrom October 2010 to January 2022, MS patients, diagnosed based on the 2017 McDonald criteria, were retrospectively reviewed. We extracted patients with infection requiring hospitalization (IRH) from medical records and matched with controls in a 1:2 ratio. Variables including clinical severity and laboratory data were compared between the infection group and controls. L_AUC was calculated along with the AUC of total white blood cells (W_AUC), neutrophils (N_AUC), lymphocytes (L_AUC), and monocytes (M_AUC). To correct for different times of blood examination and extract mean values of AUC per time point, we divided the AUC by follow-up duration. For example, in evaluating lymphocyte counts, we defined the ratio of [L_AUC] to [follow-up duration] as [L_AUC/t]. Multivariate regression analysis was conducted to extract predictive factors associated with IRH. Also, discriminative analysis was conducted using candidate variables from multivariate analysis.ResultsThe total case-control sample included 177 patients of MS with IRH (n=59) and non-IRH (controls) (n=118). Adjusted odds ratios (OR) for the risk of serious infection in patients with MS with higher baseline expanded disability status scale (EDSS) (OR 1.340, 95% confidence interval [CI] 1.070–1.670, p = 0.010) and lower ratio of L_AUC/t to M_AUC/t (OR 0.766, 95%CI 0.591–0.993, p = 0.046) were significant. Notably, the kind of treatment, including glucocorticoids (GCs), disease-modifying drugs (DMDs) and other immunosuppressants agents, and dose of GCs were not significantly associated with serious infection after correlated with EDSS and ratio of L_AUC/t to M_AUC/t. In discriminative analysis, sensitivity was 88.1% (95%CI 76.5–94.7%) and specificity was 35.6% (95%CI 27.1–45.0%), using EDSS ≥ 6.0 or ratio of L_AUC/t to M_AUC/t ≤ 3.699, while sensitivity was 55.9% (95%CI 42.5–68.6%) and specificity was 83.9% (95%CI 75.7–89.8%), using both EDSS ≥ 6.0 and ratio of L_AUC/t to M_AUC/t ≤ 3.699.ConclusionOur study revealed the impact of the ratio L_AUC/t to M_AUC/t as a novel prognostic factor for IRH. Clinicians should pay more attention to laboratory data such as lymphocyte or monocyte counts itself, directly presenting individual immunodeficiency, rather than the kind of drug to prevent infection as a clinical manifestation.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1133444/fulllymphocytemonocytearea under the curveinfectionpredictive factor
spellingShingle Junichiro Takahashi
Tomoko Okamoto
Youwei Lin
Reiko Saika
Atsuko Katsumoto
Wakiro Sato
Takashi Yamamura
Yuji Takahashi
Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis
Frontiers in Immunology
lymphocyte
monocyte
area under the curve
infection
predictive factor
title Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis
title_full Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis
title_fullStr Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis
title_full_unstemmed Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis
title_short Ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis
title_sort ratio of lymphocyte to monocyte area under the curve as a novel predictive factor for severe infection in multiple sclerosis
topic lymphocyte
monocyte
area under the curve
infection
predictive factor
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1133444/full
work_keys_str_mv AT junichirotakahashi ratiooflymphocytetomonocyteareaunderthecurveasanovelpredictivefactorforsevereinfectioninmultiplesclerosis
AT tomokookamoto ratiooflymphocytetomonocyteareaunderthecurveasanovelpredictivefactorforsevereinfectioninmultiplesclerosis
AT youweilin ratiooflymphocytetomonocyteareaunderthecurveasanovelpredictivefactorforsevereinfectioninmultiplesclerosis
AT reikosaika ratiooflymphocytetomonocyteareaunderthecurveasanovelpredictivefactorforsevereinfectioninmultiplesclerosis
AT atsukokatsumoto ratiooflymphocytetomonocyteareaunderthecurveasanovelpredictivefactorforsevereinfectioninmultiplesclerosis
AT wakirosato ratiooflymphocytetomonocyteareaunderthecurveasanovelpredictivefactorforsevereinfectioninmultiplesclerosis
AT takashiyamamura ratiooflymphocytetomonocyteareaunderthecurveasanovelpredictivefactorforsevereinfectioninmultiplesclerosis
AT yujitakahashi ratiooflymphocytetomonocyteareaunderthecurveasanovelpredictivefactorforsevereinfectioninmultiplesclerosis